4//SEC Filing
OvaScience, Inc. 4
Accession 0001179110-16-024699
$TPSTCIK 0001544227operating
Filed
May 15, 8:00 PM ET
Accepted
May 16, 8:25 AM ET
Size
10.6 KB
Accession
0001179110-16-024699
Insider Transaction Report
Form 4
OvaScience, Inc.OVAS
Dipp Michelle
DirectorPresident and CEO10% Owner
Transactions
- Purchase
Common Stock
2016-05-12$6.72/sh+14,200$95,424→ 455,161 total(indirect: By Longwood Fund III LP) - Purchase
Common Stock
2016-05-12$7.13/sh+5,600$39,928→ 460,761 total(indirect: By Longwood Fund III LP) - Purchase
Common Stock
2016-05-13$7.06/sh+16,295$115,043→ 477,056 total(indirect: By Longwood Fund III LP)
Holdings
- 971,921
Common Stock
Footnotes (4)
- [F1]This Form 4 reflects the purchase of an aggregate of 36,095 shares by the Longwood Fund III LP in the market. The securities in this line are held directly by Longwood Fund III LP. Longwood Fund III GP, LLC is the general partner of Longwood Fund III LP. Voting and investment power with respect to the shares held by Longwood Fund III LP are vested in Richard Aldrich, Michelle Dipp, M.D., Ph.D. and Christoph Westphal, M.D., Ph.D. (collectively, the "Managers"), the managers of Longwood Fund III GP, LLC. Each of the Managers disclaims beneficial ownership of the shares held by Longwood Fund III LP, except to the extent of their respective pecuniary interest therein, and the inclusion of these shares in the report shall not be deemed an admission of beneficial ownership of the shares for the purposes of Section 16 or for any other purpose.
- [F2]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.39 to $6.99, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges sent forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $7.00 to $7.58, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges sent forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $6.62 to $7.20, inclusive. The Reporting Person undertakes to provide the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges sent forth in this footnote.
Documents
Issuer
OvaScience, Inc.
CIK 0001544227
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001544227
Filing Metadata
- Form type
- 4
- Filed
- May 15, 8:00 PM ET
- Accepted
- May 16, 8:25 AM ET
- Size
- 10.6 KB